Back
Viatris, Inc. 10K Form
Sell
36
VTRS
Viatris, Inc.
Last Price:
$13.4400
Seasonality Move:
5.62%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-10 | 10Q | VTRS/Viatris, Inc. Quarterly |
| 2021-03-01 | 10K | VTRS/Viatris, Inc. Annual |
| 2020-11-10 | 10Q | VTRS/Viatris, Inc. Quarterly |
| 2020-08-12 | 10Q | VTRS/Viatris, Inc. Quarterly |
| 2020-05-12 | 10Q | VTRS/Viatris, Inc. Quarterly |
| 2020-05-07 | 10K | VTRS/Viatris, Inc. Annual |
Receive VTRS News And Ratings
See the #1 stock for the next 7 days that we like better than VTRS
VTRS Financial Statistics
Sales & Book Value
| Annual Sales: | $14.3B |
|---|---|
| Cash Flow: | $565.9M |
| Price / Cash Flow: | 8.38 |
| Annual Sales: | $12.78 |
| Price / Book: | 1.04 |
Profitability
| EPS (TTM): | -2.96030 |
|---|---|
| Net Income (TTM): | $-3.5B |
| Gross Margin: | $5.6B |
| Return on Equity: | -22.03% |
| Return on Assets: | -9.08% |
Viatris, Inc. Earnings Forecast
Key Viatris, Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for VTRS is 39.52%.
-
The Selling, General & Administrative Expenses for VTRS have been equal to 26.54% of Gross Profit Margin.
-
The Research & Development expenses have been 6.66% of Revenue.
-
The Net Earning history of VTRS is -24.59% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 20 years.
Viatris, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | VTRS |
| CUSIP: | 92556V |
| Website: | viatris.com |
Debt
| Debt-to-Equity Ratio: | 1 |
|---|---|
| Current Ratio: | 1.3 |
| Quick Ratio: | 0.59 |
Price-to-Earnings
| Trailing P/E Ratio: | 224.8 |
|---|---|
| Forward P/E Ratio: | 4.97 |
VTRS Technical Analysis vs Fundamental Analysis
Sell
36
Viatris, Inc. (VTRS)
is a Sell
Is Viatris, Inc. a Buy or a Sell?
-
Viatris, Inc. stock is rated a SellThe current Viatris, Inc. [VTRS] share price is $13.4400. The Score for VTRS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.